The trial will evaluate the immunogenicity and safety of three consecutive vaccine lots of the freeze-dried formulation of MVA-BN®smallpox vaccine.
A new technique that mimics the way the body copies its own DNA may allow the creation of a gene in a single day.
Researchers developed a new vaccine against anthrax that can generate an immune response to anthrax toxin as well as its spores rather than just the toxin as existing vaccines do.
Treatment with BAT® [Botulism Antitoxin Heptavalent (Equine)] was associated with shorter hospital and intensive care unit stays.
The three treatments approved for shipment to Uganda were ZMapp, Regeneron, and Remdesivir.
Researchers identified an experimental antiviral drug that cures mice infected with Bourbon virus. Favipiravir is approved in Japan but not the US.
A new vaccine provided complete protection, in nonhuman primates, against three types of equine encephalitic viruses that are possible bioterrorism agents.
The $16.5 million contract from the US Biomedical Advanced Research and Development Authority (BARDA), with an option for an additional $30 million, calls for a drug for Marburg virus and Ravn virus to be taken into early human clinical testing.
Agricultural authorities in South China's Hainan Province confirmed that a potential African swine fever vaccine has shown "certain preventive effects" after clinical trials.
The Global Control of African Swine Fever resolution provides a framework to address this global threat through collaborative preparedness, prevention, detection and control measures.